Pfizer Inc

Latest in Pfizer Inc

Pfizer says its experimental drug for deadly condition that causes appetite and weight loss in cancer patients shows positive trial results
by thinkia.org.in 7 months ago
Pfizer‘s experimental drug for a common, life-threatening condition that causes cancer patients to lose their appetite and weight showed positive …
Moderna shares plunge on plans to cut $1.1 billion in costs, launch 10 new products by 2027
by thinkia.org.in 7 months ago
Moderna headquarters, exterior view, Cambridge, Massachusetts, USA. Plexi Images | GHI | UCG | Universal Images Group | Getty Images Moderna …
FDA authorizes Novavax’s updated Covid vaccine, paving way for fall rollout
by thinkia.org.in 7 months ago
A vial labelled “Novavax V COVID-19 Vaccine” is seen in this illustration taken January 16, 2022. Dado Ruvic | Reuters …
U.S. will again offer free at-home Covid tests starting in late September
by thinkia.org.in 7 months ago
Images By Tang Ming Tung | DigitalVision | Getty Images The Biden administration on Friday said it will resume offering …
FDA approves updated Pfizer, Moderna Covid vaccines as virus surges; shots to be available within days
by thinkia.org.in 7 months ago
Pfizer COVID-19 vaccine. Courtesy: Pfizer The Food and Drug Administration on Thursday approved updated Covid vaccines from Pfizer and Moderna, …
Moderna beats estimates but slashes guidance on low EU sales, competitive U.S. vaccine market
by thinkia.org.in 8 months ago
Moderna on Thursday reported second-quarter revenue that beat expectations but slashed its full-year sales guidance, citing lower expected sales in …
Stock futures are flat in overnight trading ahead of key corporate earnings: Live updates
by thinkia.org.in 8 months ago
Traders on the floor of the New York Stock Exchange on Aug. 4, 2022. Source: NYSE Stock futures were flat …
Bristol Myers Squibb beats earnings estimates, raises outlook as drugmaker slashes costs
by thinkia.org.in 8 months ago
The Bristol Myers Squibb research and development center at Cambridge Crossing in Cambridge, Massachusetts, on Dec. 27, 2023. Adam Glanzman …
Pfizer’s gene therapy for rare genetic bleeding disorder succeeds in late-stage trial
by thinkia.org.in 8 months ago
Kena Betancur | Corbis News | Getty Images Pfizer on Wednesday said its experimental gene therapy for a rare genetic …
Pfizer moves forward with once-daily version of weight loss pill after setbacks
by thinkia.org.in 9 months ago
Pfizer on Thursday said it will move forward with a once-daily version of its weight loss pill, danuglipron, after it …

Vaccine stocks fall after key FDA official resigns in protest of RFK Jr.

Eli Lilly will soon release key data on its weight loss pill. Here’s why it could be a game-changer

Once high-flying Bluebird Bio sells itself to private equity after tough times for the gene therapy maker

Trump is unlikely to end Medicare drug price talks — here’s what that means for patients and pharma

Super Bowl 59 live updates: Chiefs, Eagles, Kendrick and star-studded commercials

Latest in Pfizer Inc

Pfizer says its experimental drug for deadly condition that causes appetite and weight loss in cancer patients shows positive trial results

Moderna shares plunge on plans to cut $1.1 billion in costs, launch 10 new products by 2027

FDA authorizes Novavax’s updated Covid vaccine, paving way for fall rollout

U.S. will again offer free at-home Covid tests starting in late September

FDA approves updated Pfizer, Moderna Covid vaccines as virus surges; shots to be available within days

Moderna beats estimates but slashes guidance on low EU sales, competitive U.S. vaccine market

Stock futures are flat in overnight trading ahead of key corporate earnings: Live updates

Bristol Myers Squibb beats earnings estimates, raises outlook as drugmaker slashes costs

Pfizer’s gene therapy for rare genetic bleeding disorder succeeds in late-stage trial

Pfizer moves forward with once-daily version of weight loss pill after setbacks

Editors' Picks

Resources | The VHL Handbook | Surveillance Guidelines

Latest Posts

Follow us